14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Amicus Therapeutics Stock Forecast

NASDAQ:FOLD BUY SELL

$7.94 (2.32%)

Volume: 2.372M

Closed: May 23, 2022

Hollow Logo Score: 1.742

Amicus Therapeutics Stock Forecast

BUY SELL NASDAQ:FOLD
$7.94 (2.32%)

Volume: 2.372M

Closed: May 23, 2022

Score Hollow Logo 1.742

Amicus Therapeutics Stock Forecast NASDAQ:FOLD

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-02-24 76.32% SVB Leerink $16.00 $14.00 Maintains Outperform
2022-01-14 101.51% SVB Leerink $12.00 $16.00 Upgrades Market Perform Outperform
2022-01-13 88.92% Cantor Fitzgerald $16.00 $15.00 Maintains Overweight
2021-11-15 101.51% Stifel $12.00 $16.00 Upgrades Hold Buy
2021-09-30 101.51% JP Morgan $16.00 Upgrades Neutral Overweight
2021-09-30 51.13% SVB Leerink $13.00 $12.00 Maintains Market Perform
2021-05-27 - Needham - Initiates Coverage On Hold
2021-05-21 101.51% UBS $16.00 Initiates Coverage On Buy
2021-04-14 - Cantor Fitzgerald - Upgrades Neutral Overweight
2021-03-22 63.73% SVB Leerink $15.00 $13.00 Maintains Market Perform
2021-03-02 63.73% Stifel $13.00 Initiates Coverage On Hold
2021-02-12 114.11% Cantor Fitzgerald $30.00 $17.00 Downgrades Overweight Neutral
2021-02-12 139.29% JP Morgan $19.00 Downgrades Overweight Neutral
2021-02-12 88.92% SVB Leerink $30.00 $15.00 Downgrades Outperform Market Perform
2020-12-14 277.83% SVB Leerink $24.00 $30.00 Maintains Outperform
2020-11-11 164.48% Berenberg $21.00 Initiates Coverage On Hold
2020-11-06 202.27% SVB Leerink $19.00 $24.00 Maintains Outperform
2020-08-11 151.89% Citigroup $15.00 $20.00 Maintains Buy
2020-06-17 139.29% BTIG $19.00 Initiates Coverage On Buy
2020-02-04 151.89% Cantor Fitzgerald $19.00 $20.00 Assumes Overweight

FOLD Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $8.45 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -20.59% during the next 3 months and, with a 90% probability hold a price between $4.66 and $6.71 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-25 $5.83 $7.13 $8.42
2022-05-26 $5.80 $7.09 $8.38
2022-05-27 $5.76 $7.05 $8.35
2022-05-31 $5.73 $7.02 $8.31
2022-06-01 $5.69 $6.98 $8.27
2022-06-02 $5.66 $6.95 $8.24
2022-06-03 $5.62 $6.91 $8.20
2022-06-06 $5.58 $6.87 $8.17
2022-06-07 $5.55 $6.84 $8.13
2022-06-08 $5.51 $6.80 $8.09
2022-06-09 $5.48 $6.77 $8.06
2022-06-10 $5.44 $6.73 $8.02
2022-06-13 $5.40 $6.70 $7.99
2022-06-14 $5.37 $6.66 $7.95
2022-06-15 $5.33 $6.62 $7.91
2022-06-16 $5.30 $6.59 $7.88
2022-06-17 $5.26 $6.55 $7.84
2022-06-21 $5.22 $6.52 $7.81
2022-06-22 $5.19 $6.48 $7.77
2022-06-23 $5.15 $6.44 $7.74
2022-06-24 $5.12 $6.41 $7.70
2022-06-27 $5.08 $6.37 $7.66
2022-06-28 $5.04 $6.34 $7.63
2022-06-29 $5.01 $6.30 $7.59
2022-06-30 $4.97 $6.26 $7.56
2022-07-01 $4.94 $6.23 $7.52
2022-07-05 $4.90 $6.19 $7.48
2022-07-06 $4.86 $6.16 $7.45
2022-07-07 $4.83 $6.12 $7.41
2022-07-08 $4.79 $6.08 $7.38

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company is also developing SD-101, which is in Phase III clinical s... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT